Lennon VA. : Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature, Neurology 44 : 2236-2240, 1994.
Weinshenker BG, Wingerchunk DM, Pittock SJ., Lucchinetti CF, Lennon VA. NMO-IgG : a specific biomarker for neuromyelitis optica. Dis Markers. 22(4) : 197-206, 2006.
Genain CP, Cannella B, Hauser SL, Raine CS.: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine 5: 170-175, 1999.
Mayer MC, Meinl E. : Glycoproteins as targets of autoantibodies in CNS inflammation : MOG and more. Therapeutic Advances in Neurological Disorders 5 : 147-159, 2012.
Reindl M, Di Pauli F, Rostasy K, Berger T. : The spectrum of MOG autoantibody-associated demyelinating diseases. Nature Reviews Neurology, 9, 455-461, 2013.